Omega Healthcare (OHI) Receives a Hold from JMP Securities

JMP Securities analyst Aaron Hecht reiterated a Hold rating on Omega Healthcare (OHIResearch Report) today. The company’s shares closed last Monday at $28.47, close to its 52-week low of $26.92.

According to, Hecht is a 4-star analyst with an average return of 11.1% and a 58.7% success rate. Hecht covers the Financial sector, focusing on stocks such as Chicago Atlantic Real Estate ate Finance Inc, Bluerock Residential Growth, and Plymouth Industrial Reit.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Omega Healthcare with a $32.43 average price target, which is a 12.2% upside from current levels. In a report issued on February 1, Credit Suisse also initiated coverage with a Hold rating on the stock with a $31.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Omega Healthcare’s market cap is currently $6.9B and has a P/E ratio of 16.63.

Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of OHI in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Omega Healthcare Investors, Inc. engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities. Its portfolio consists of long-term leases and mortgage agreements. The company was founded on March 31, 1992 and is headquartered in Hunt Valley, MD.

Read More on OHI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More